Search Result "ALK rearrangement"
The ALK Gene, An Attractive Target for Inhibitor Development
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1406-1419
Author(s): Carmen J. Tartari, Leonardo Scapozza, Carlo Gambacorti-Passerini
Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies
Journal: Current Clinical Pharmacology
Volume: 11 Issue: 2 Year: 2016 Page: 77-87
Author(s): Francesca Casaluce,Assunta Sgambato,Paola Claudia Sacco,Giovanni Palazzolo,Paolo Maione,Antonio Rossi,Fortunato Ciardiello,Cesare Gridelli
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents
Journal: Current Drug Metabolism
Volume: 16 Issue: 7 Year: 2015 Page: 585-596
Author(s): Francesca Simionato,Melissa Frizziero,Carmine Carbone,Giampaolo Tortora,Davide Melisi
Research Progress on the Drug Resistance of ALK Kinase Inhibitors
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 14 Year: 2022 Page: 2456-2475
Author(s): Zhen Li,Fang Liu,Shuang Wu,Shi Ding,Ye Chen
A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements andMutations: Implications for Gastric Carcinogenesis and Target Therapy
Journal: Current Protein & Peptide Science
Volume: 25 Issue: 7 Year: 2024 Page: 539-552
Author(s): Felipe Pantoja Mesquita,Luina Benevides Lima,Emerson Lucena da Silva,Pedro Filho Noronha Souza,Maria Elisabete Amaral de Moraes,Rommel Mario Rodrigues Burbano,Raquel Carvalho Montenegro
A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 4 Year: 2015 Page: 327-336
Author(s): Nick Ka Ming Yau,Andrew Yuon Fong,Hiu Fung Leung,Krista Roberta Verhoeft,Qin Ying Lim,Wai Yip Lam,Ian Chi Kei Wong,Vivian Wai Yan Lui
MET and ALK as Targets for the Treatment of NSCLC
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3914-3932
Author(s): Capelletti M,Gelsomino F.,Tiseo M.
ALK-Positive Non-Small Cell Lung Cancer; Potential Combination Drug Treatments
Journal: Current Cancer Drug Targets
Volume: 21 Issue: 9 Year: 2021 Page: 737-748
Author(s): Shrestha Nensi,John Ashton
EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11 Issue: 4 Year: 2016 Page: 393-400
Author(s): Ramon Andrade De Mello,Davi J. J. Liu,Pedro N. Aguiar,Hakaru Tadokoro
3D-QSAR and Docking Studies on 2-acyliminobenzimidazoles Derivatives as Potent ALK Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 12 Issue: 3 Year: 2015 Page: 219-233
Author(s): Qianqian Lva,Zhi Wang,Zhonghua Wanga,Fanhong Wu,Liping Cheng